Cargando…

Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2

Doxorubicin- (DOX-) induced cardiomyocyte loss results in irreversible heart failure, which limits the clinical applications of DOX. Currently, there are no drugs that can effectively treat DOX-related cardiotoxicity. Follistatin-like 1 (FSTL1) has been reported to be a transforming growth factor-be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yintao, Sun, Jingjing, Zhang, Wei, Peng, Meng, Chen, Jun, Zheng, Lu, Zhang, Xiangqin, Yang, Haibo, Liu, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421745/ https://www.ncbi.nlm.nih.gov/pubmed/32831995 http://dx.doi.org/10.1155/2020/3598715

Ejemplares similares

Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice
por: Zhang, Wei, et al.
Publicado: (2017)

Transcriptional activation of follistatin by Nrf2 protects pulmonary epithelial cells against silica nanoparticle-induced oxidative stress
por: Lin, Chen, et al.
Publicado: (2016)

Soluble Epoxide Hydrolase Inhibition Protected against Diabetic Cardiomyopathy through Inducing Autophagy and Reducing Apoptosis Relying on Nrf2 Upregulation and Transcription Activation
por: Fang, Qin, et al.
Publicado: (2022)

Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity
por: Fan, Nengguang, et al.
Publicado: (2013)

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?
por: Kaplan, Huseyin, et al.
Publicado: (2023)

miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice
por: Hu, Xiaoping, et al.
Publicado: (2019)

Follistatin-like 1 in development and human diseases
por: Mattiotti, Andrea, et al.
Publicado: (2018)

Melatonin protects against arsenic trioxide-induced liver injury by the upregulation of Nrf2 expression through the activation of PI3K/AKT pathway
por: Zhang, Yue, et al.
Publicado: (2016)

Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis
por: Qin, Yating, et al.
Publicado: (2022)

Follistatin‐like 1 promotes cardiac fibroblast activation and protects the heart from rupture
por: Maruyama, Sonomi, et al.
Publicado: (2016)

Follistatin-Like Proteins: Structure, Functions and Biomedical Importance
por: Parfenova, Olga K., et al.
Publicado: (2021)

S-diclofenac Protects against Doxorubicin-Induced Cardiomyopathy in Mice via Ameliorating Cardiac Gap Junction Remodeling
por: Zhang, Huili, et al.
Publicado: (2011)

Protective Effects of Dexazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1
por: Zhang, Haiyan, et al.
Publicado: (2021)

Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer
por: Liu, Zhen, et al.
Publicado: (2023)

Protective effect of cafestol against doxorubicin-induced cardiotoxicity in rats by activating the Nrf2 pathway
por: Al-Kenany, Sara A., et al.
Publicado: (2023)

Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model
por: Shen, Han, et al.
Publicado: (2019)

Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1/Nrf2 Signaling Pathway Activation
por: Li, Danlei, et al.
Publicado: (2022)

Follistatin like-1 aggravates silica-induced mouse lung injury
por: Fang, Yinshan, et al.
Publicado: (2017)

Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells
por: Shi, Feng-Tao, et al.
Publicado: (2011)

Role of follistatin-like 1 levels and functions in calcific aortic stenosis
por: Zhang, Qianru, et al.
Publicado: (2023)

Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment
por: Xiong, Chen, et al.
Publicado: (2018)

Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
por: Jiang, Zhaohui, et al.
Publicado: (2020)

Upregulation of follistatin and low apoptotic activity in intraductal oncocytic papillary neoplasm of the pancreatobiliary system
por: Nakahodo, Jun, et al.
Publicado: (2020)

Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3
por: Yamada, Shinnosuke, et al.
Publicado: (2018)

GDF8 Promotes the Cell Invasiveness in Human Trophoblasts by Upregulating the Expression of Follistatin-Like 3 Through the ALK5-SMAD2/3 Signaling Pathway
por: Xie, Jiamin, et al.
Publicado: (2020)

Hypo-glycosylated follistatin-like 1 for new cardiomyocyte formation
por: Kerkelä, Risto
Publicado: (2022)

Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
por: El-Agamy, Dina S, et al.
Publicado: (2018)

Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers
por: Tian, Shifeng, et al.
Publicado: (2022)

Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
por: Wang, Yinhui, et al.
Publicado: (2021)

Choline Protects the Heart from Doxorubicin-Induced Cardiotoxicity through Vagal Activation and Nrf2/HO-1 Pathway
por: Guo, Fuding, et al.
Publicado: (2022)

Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects
por: Li, Ran, et al.
Publicado: (2019)

Protective Effect of Thymoquinone against Cyclophosphamide-Induced Hemorrhagic Cystitis through Inhibiting DNA Damage and Upregulation of Nrf2 Expression
por: Gore, Prashant R., et al.
Publicado: (2016)

The BMP Antagonist Follistatin-Like 1 Is Required for Skeletal and Lung Organogenesis
por: Sylva, Marc, et al.
Publicado: (2011)

Prognostic value of follistatin-like 3 in human invasive breast cancer
por: Couto, Henrique L., et al.
Publicado: (2017)

Clinical implications of circulating follistatin-like protein-1 in hemodialysis patients
por: Kim, Dae Kyu, et al.
Publicado: (2023)

Follistatin and the Breast Implant Capsule
por: Frenkiel, Brett A., et al.
Publicado: (2017)

Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats
por: Ma, Hui, et al.
Publicado: (2017)

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
por: Sun, Jing, et al.
Publicado: (2013)

Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma
por: Zhang, Deng-Yong, et al.
Publicado: (2020)

Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites
por: Zhang, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nikdnsnakquugg87ord80473mj